Uncategorized

CHITOSE Group Obtains Funding from Japanese Government-affiliated NEDO for Green Innovation Fund of USD400M Range

Chitose Laboratory Corp. has won funding from a Japanese government-affiliated entity for a project on the self-proposed theme of “Building a global industry originating in Japan based on the direct use of CO2 through photosynthesis” for the “Green Innovation Fund Project : Promotion of Carbon Recycling Using CO2 from Biomanufacturing Technology as a Direct Raw […]

CHITOSE Group Obtains Funding from Japanese Government-affiliated NEDO for Green Innovation Fund of USD400M Range Read More »

ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with Leucid Bio

ImaginAb Inc. is pleased to announce the execution of a new non-exclusive License and Supply Agreement with Leucid Bio, a biotech company pursuing a differentiated approach to develop next generation Chimeric Antigen Receptor T-cell therapies using the Company’s proprietary Lateral CAR Platform.

ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with Leucid Bio Read More »

GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications

GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a new study in Nature Communications, showcasing the company’s novel AI-based liquid biopsy technology.

GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications Read More »

Scroll to Top